| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.57e-04 | 8 | 48 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.57e-04 | 8 | 48 | 2 | GO:0004972 | |
| GeneOntologyBiologicalProcess | head development | SEMA6B CWH43 HTR6 SZT2 ARX EXT1 GRIN2C GRIN2D HERC1 AXIN1 SEZ6 | 7.96e-06 | 919 | 49 | 11 | GO:0060322 |
| GeneOntologyBiologicalProcess | brain development | 2.79e-05 | 859 | 49 | 10 | GO:0007420 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.92e-04 | 9 | 49 | 2 | GO:0017146 | |
| Domain | Glyco_trans_31 | 6.97e-04 | 16 | 46 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 6.97e-04 | 16 | 46 | 2 | PF01762 | |
| Domain | Iontro_rcpt | 8.85e-04 | 18 | 46 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 8.85e-04 | 18 | 46 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 8.85e-04 | 18 | 46 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 8.85e-04 | 18 | 46 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 8.85e-04 | 18 | 46 | 2 | SM00918 | |
| Domain | Lig_chan | 8.85e-04 | 18 | 46 | 2 | PF00060 | |
| Domain | PBPe | 8.85e-04 | 18 | 46 | 2 | SM00079 | |
| Domain | Laminin_EGF | 3.35e-03 | 35 | 46 | 2 | PF00053 | |
| Domain | EGF_Lam | 3.35e-03 | 35 | 46 | 2 | SM00180 | |
| Domain | EGF_1 | 3.53e-03 | 255 | 46 | 4 | PS00022 | |
| Domain | ANF_lig-bd_rcpt | 3.74e-03 | 37 | 46 | 2 | IPR001828 | |
| Domain | ANF_receptor | 3.74e-03 | 37 | 46 | 2 | PF01094 | |
| Domain | Laminin_EGF | 3.94e-03 | 38 | 46 | 2 | IPR002049 | |
| Domain | EGF_2 | 4.05e-03 | 265 | 46 | 4 | PS01186 | |
| Domain | Peripla_BP_I | 4.15e-03 | 39 | 46 | 2 | IPR028082 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 5.29e-05 | 5 | 33 | 2 | MM15655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 5.29e-05 | 5 | 33 | 2 | M47667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 7.92e-05 | 6 | 33 | 2 | M47668 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 3.46e-04 | 12 | 33 | 2 | M47953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 5.47e-04 | 15 | 33 | 2 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 7.94e-04 | 18 | 33 | 2 | M47761 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 7.94e-04 | 18 | 33 | 2 | M48098 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 8.86e-04 | 19 | 33 | 2 | M47677 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 9.83e-04 | 20 | 33 | 2 | MM1445 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.83e-04 | 20 | 33 | 2 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.09e-03 | 21 | 33 | 2 | M27736 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.09e-03 | 21 | 33 | 2 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.09e-03 | 21 | 33 | 2 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.09e-03 | 21 | 33 | 2 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.19e-03 | 22 | 33 | 2 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.30e-03 | 23 | 33 | 2 | M27949 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29651654 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 31110197 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29317596 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 35057644 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33766086 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23770366 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 31786200 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 9718984 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 35867797 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 33421565 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 9480759 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 8699248 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 9768843 | ||
| Pubmed | Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs. | 1.31e-05 | 4 | 52 | 2 | 36309015 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.93e-05 | 560 | 52 | 7 | 21653829 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 26875626 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 26919761 | ||
| Pubmed | Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. | 2.19e-05 | 5 | 52 | 2 | 7518475 | |
| Pubmed | Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. | 2.19e-05 | 5 | 52 | 2 | 7518474 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 9147327 | ||
| Pubmed | Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. | 2.19e-05 | 5 | 52 | 2 | 7510577 | |
| Pubmed | Neurotransmission and bipolar disorder: a systematic family-based association study. | 2.19e-05 | 5 | 52 | 2 | 18444252 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 8015722 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 15003177 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 7723623 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 8756432 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 12082569 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 21945132 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 18233995 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 11488959 | ||
| Pubmed | Developmental changes in distribution of NMDA receptor channel subunit mRNAs. | 2.19e-05 | 5 | 52 | 2 | 1493227 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 8036251 | ||
| Pubmed | NMDA receptor activation by HIV-Tat protein is clade dependent. | 2.19e-05 | 5 | 52 | 2 | 19020013 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 7929904 | ||
| Pubmed | Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. | 3.28e-05 | 6 | 52 | 2 | 25760043 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 23665428 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 8996814 | ||
| Pubmed | Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. | 3.28e-05 | 6 | 52 | 2 | 9458051 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 15317856 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.44e-05 | 1105 | 52 | 9 | 35748872 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 12103442 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 23267846 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 19036954 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 22833210 | ||
| Pubmed | HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. | 4.58e-05 | 7 | 52 | 2 | 22940423 | |
| Pubmed | Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. | 6.10e-05 | 8 | 52 | 2 | 8804048 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 17360663 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8724036 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8845955 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8822372 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 21106831 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8563977 | ||
| Pubmed | HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. | 6.10e-05 | 8 | 52 | 2 | 8821747 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 10448428 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 7695237 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 8955056 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 10555109 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 17526495 | ||
| Pubmed | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. | 7.84e-05 | 9 | 52 | 2 | 22552781 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 21670103 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 21491143 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 16554481 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 9892651 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 19332541 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 8581564 | ||
| Pubmed | HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells. | 1.20e-04 | 11 | 52 | 2 | 24739951 | |
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 9647694 | ||
| Pubmed | Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. | 1.20e-04 | 11 | 52 | 2 | 16481105 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 12815021 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 11937501 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 8665664 | ||
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 15749123 | ||
| Pubmed | Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. | 2.27e-04 | 15 | 52 | 2 | 21948112 | |
| Pubmed | Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. | 2.27e-04 | 15 | 52 | 2 | 10479680 | |
| Pubmed | 2.54e-04 | 205 | 52 | 4 | 20436479 | ||
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 24086760 | ||
| Pubmed | Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits. | 3.30e-04 | 18 | 52 | 2 | 9011744 | |
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 22114277 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 5.93e-04 | 24 | 52 | 2 | 35746896 | |
| Pubmed | 6.43e-04 | 25 | 52 | 2 | 29475039 | ||
| Pubmed | Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death. | 6.96e-04 | 26 | 52 | 2 | 9745929 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 7.45e-04 | 118 | 52 | 3 | 19156168 | |
| Pubmed | 9.29e-04 | 30 | 52 | 2 | 18603407 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 9.29e-04 | 30 | 52 | 2 | 32882513 | |
| Pubmed | 1.12e-03 | 33 | 52 | 2 | 19526283 | ||
| Pubmed | 1.49e-03 | 38 | 52 | 2 | 25613138 | ||
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 5.94e-05 | 7 | 31 | 2 | 1201 | |
| GeneFamily | Beta 3-glycosyltransferases | 7.67e-04 | 24 | 31 | 2 | 426 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 169 | 51 | 5 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| Drug | L-cycloserine | 1.45e-05 | 66 | 51 | 4 | CID000000401 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 4.12e-05 | 30 | 51 | 3 | CID000001226 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 4.90e-05 | 5 | 51 | 2 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 4.90e-05 | 5 | 51 | 2 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 4.90e-05 | 5 | 51 | 2 | ctd:C491996 | |
| Drug | SDZ EAA 494 | 4.90e-05 | 5 | 51 | 2 | ctd:C065286 | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 5384_DN | |
| Drug | Naphthols | 7.34e-05 | 6 | 51 | 2 | ctd:D009284 | |
| Drug | Meperidine | 7.34e-05 | 6 | 51 | 2 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 7.34e-05 | 6 | 51 | 2 | CID000004025 | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2888_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 4501_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6073_UP | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 6098_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 6128_UP | |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 6470_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 3619_UP | |
| Drug | Tenocyclidine | 1.03e-04 | 7 | 51 | 2 | DB01520 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 1.03e-04 | 7 | 51 | 2 | ctd:C050592 | |
| Drug | tetrazol-5-yl)glycine | 1.03e-04 | 7 | 51 | 2 | CID000126383 | |
| Drug | homoquinolinate | 1.03e-04 | 7 | 51 | 2 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 1.03e-04 | 7 | 51 | 2 | CID001502069 | |
| Drug | Oxadiazoles | 1.31e-04 | 44 | 51 | 3 | ctd:D010069 | |
| Drug | AC1L1JJR | 1.31e-04 | 44 | 51 | 3 | CID000005072 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 1.37e-04 | 8 | 51 | 2 | CID000081143 | |
| Drug | ES-242-1 | 1.37e-04 | 8 | 51 | 2 | CID000131976 | |
| Drug | SDZ 220-581 | 1.37e-04 | 8 | 51 | 2 | CID000128019 | |
| Drug | 3alpha5betaHS | 1.37e-04 | 8 | 51 | 2 | CID000165024 | |
| Drug | neramexane | 1.37e-04 | 8 | 51 | 2 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 1.37e-04 | 8 | 51 | 2 | CID000280973 | |
| Drug | L-687,414 | 1.37e-04 | 8 | 51 | 2 | CID000125556 | |
| Drug | Phenanthrenes | 1.75e-04 | 9 | 51 | 2 | ctd:D010616 | |
| Drug | imipramine | 1.79e-04 | 235 | 51 | 5 | CID000003696 | |
| Drug | 1c88 | 1.83e-04 | 126 | 51 | 4 | CID000444766 | |
| Drug | M100907 | 2.04e-04 | 51 | 51 | 3 | CID000060858 | |
| Drug | piperidine | 2.06e-04 | 130 | 51 | 4 | CID000008082 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.98e-05 | 49 | 52 | 3 | DOID:0060037 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WHELGHARPPVPGQC | 166 | P50406 | |
| FPHGPKPGSSHRPWQ | 266 | P49902 | |
| WAPAEAHPLSPQGHP | 56 | P17405 | |
| PAAHSPWACGPPHWG | 36 | Q495Z4 | |
| LQPSPSFCLHHPWPD | 141 | Q96F81 | |
| SHHDTWPPACPPLEP | 156 | O00391 | |
| WAVHPPAPAHPSLLD | 31 | Q9H0B3 | |
| HCPSVSHRAQPWPHP | 36 | O75106 | |
| QPCPPAHWGPNCIHT | 701 | Q96KG7 | |
| QAGHTPRPHPWGCPA | 81 | P56730 | |
| PLLRPPAHLHFFPHW | 111 | Q8N3F9 | |
| GRCHSAAWTAPPVPP | 4351 | Q15751 | |
| LHHGPLCLGEPAPFW | 36 | O43593 | |
| SPPGAALPHPHLLWR | 206 | A6NFC9 | |
| HGPPRCSAAWKPPQL | 796 | Q9UQ05 | |
| PDIHPIGWCDVTGHP | 346 | Q8NA19 | |
| PHQGPWGAPSPQAHL | 371 | Q86UY5 | |
| WGAPSPQAHLSPRPH | 376 | Q86UY5 | |
| HPHPNTCPRLPACWL | 136 | B2CW77 | |
| PFHPRVHWAAPPSLS | 6 | Q9BZ23 | |
| PPTWPPGPAHHSCHQ | 366 | P20393 | |
| PGQAPCPGIHHTEWA | 406 | Q9UFP1 | |
| RKYSAPSHWCPPDPH | 76 | A0A1W2PR19 | |
| PSHWCPPDPHARARV | 81 | A0A1W2PR19 | |
| LHHPSPDHFWPRFPD | 46 | Q16394 | |
| WAPPTPRHSRCPPNH | 66 | Q9C0J1 | |
| HPWQGRCPPIPAHGK | 46 | P59091 | |
| AWGHPCEMCPAQPHP | 216 | P35555 | |
| WPIPAPPGCLRSHQH | 206 | Q2WGN9 | |
| HKLPPAPAWHHFPPR | 436 | O15169 | |
| ASPFPPHHPALDSAW | 416 | Q96QS3 | |
| LGAPHPPPRDHLIWS | 26 | A6NNB3 | |
| RPPVHQGHPSPRCAW | 161 | Q9BYE0 | |
| QVGSEPPCHPGHSWR | 201 | Q8IVE0 | |
| PPCHPGHSWRKKSAP | 206 | Q8IVE0 | |
| PRCPHCNDYWPHEIP | 226 | Q8WV22 | |
| RWAVSGHPHPGPDPN | 221 | Q9H720 | |
| LCGHTWGLPHAPPSP | 1346 | Q5T011 | |
| WPWRPATPRHPHPCL | 196 | Q8WTR8 | |
| ACHPAAWSRGPAPPL | 1156 | Q9H6K5 | |
| HACHPPPWLAPRQAA | 1991 | Q6ZRS2 | |
| WRLLHGPHGPACAHP | 376 | Q6UX72 | |
| GHPAPSPIWRHAALG | 31 | Q2HXU8 | |
| PTPHPHPHALGPRAW | 721 | Q9H3T3 | |
| GPRAWDHGHPLLPAS | 731 | Q9H3T3 | |
| SPKLHGCWDPHSLHP | 116 | Q9HC29 | |
| AHLWTHAPTRPYPCP | 136 | Q86XF7 | |
| VPGHPSHWSDPPPIC | 881 | Q53EL9 | |
| PHHRPQPRSVPGWDS | 141 | P49765 | |
| HDGAPPKAPPNGHWR | 2421 | Q96AY4 | |
| RSGWHHGPPAVLPPL | 1116 | P31629 | |
| PAPSWPIHGPVIHSA | 1501 | Q5TAX3 | |
| PWEHAPRPHFPLVPA | 1581 | Q5TAX3 | |
| APWPKPGCASPHGSH | 101 | Q6UXR8 | |
| PGCASPHGSHWPSIL | 106 | Q6UXR8 | |
| HPRLCLQWHPEPPLA | 2636 | Q9Y493 | |
| KSLCPDTWPHWHGPP | 646 | Q8N1T3 | |
| HLPFCWGAVCPHLPP | 1156 | Q14957 | |
| WGAVCPHLPPCASHG | 1161 | Q14957 | |
| PHLPPCASHGSWLSG | 1166 | Q14957 | |
| RCPHAAHWGPPLPTA | 1296 | O15399 |